Papa inoa o 13 mau Hui Laau Laau Lapaau ma Swiss

Ka papa inoa o nā luna kiʻekiʻe ma Swiss Nā ʻoihana lāʻau lapaʻau i hoʻokaʻawale ʻia ma muli o ka huina kālā o ka makahiki i hala. ʻO Roche ka nui loa ʻOihana Kamepiula ma Switzerland me ka loaʻa ʻana o $ 66 Billion i ka makahiki i hala a ukali ʻia e Novartis a me Vifor.

Roche – Nui loa ʻoihana lāʻau lapaʻau ma Swiss: I loko o ka mōʻaukala 125-makahiki, ua ulu ʻo Roche i kekahi o nā ʻoihana biotech nui loa o ka honua, a he alakaʻi alakaʻi i nā diagnostics in-vitro a me kahi mea hoʻolako honua o nā hoʻonā hoʻololi hou i nā wahi maʻi nui.

Ka papa inoa o nā ʻoihana Lapaʻau Kiʻekiʻe ma Swiss

No laila eia ka papa inoa o nā mea kiʻekiʻe ma Swiss mea lāʻau lapaʻau ʻO nā hui ma ka huina o nā Kūʻai (Revenue).

S.NODescriptionKa hōʻiliʻili kālā limahanaʻAiʻe-i-Equity ratio Hoʻi i ka Pono Hōʻailona Kūʻai
1POHAKU $ 65,980 Million1014650.440.4RO
2NOVARTIS $ 51,668 Million1057940.617.3NOVN
3VIFOR $ 1,930 Million26000.25.9VIFN
4SIEGFRIED $ 956 Million25000.913.9SFZN
5BACHEM $ 455 Million15290.321.3BANB
6BASILEA $ 144 Million150-2.9BSLN
7IDORSIA $ 81 Million5.5-237.9MANAʻO
8COSMO PHARM $ 74 Million2650.5-2.8COPN
9SANTERA $ 17 Million915.2-1316.2SAN
10SPEXIS N$ 16 Million52-1.6-347.9SPEX
11EVOLVA N$ 9 Million650.1-29.1EVE
12ʻO NEWRON PHARMA N$ 6 Million3.1-110.5NWN
13ADDEX N$ 4 Million270.0-89.8ADXN
ʻO ka papa inoa o nā hui lāʻau lapaʻau ma Swiss

ʻO Novartis - ʻO ka hui ʻelua Swiss Pharma Company

Ua hana ʻia ʻo Novartis ma 1996 ma o ka hui ʻana o Ciba-Geigy a me Sandoz. ʻO Novartis a me kāna mau ʻoihana mua i ʻike i nā aʻa ma mua o 250 mau makahiki, me ka mōʻaukala waiwai o ka hoʻomohala ʻana i nā huahana hou.

Ke hana hou nei ʻo Novartis i ka lāʻau lapaʻau e hoʻomaikaʻi a hoʻonui i ke ola o nā kānaka. Ma ke ʻano he hui lāʻau lapaʻau koʻikoʻi o ka honua, hoʻohana ka hui i nā ʻepekema hou a me nā ʻenehana kikohoʻe e hana i nā lāʻau lapaʻau hoʻololi i nā wahi o ka pono olakino. I kā mākou ʻimi e ʻimi i nā lāʻau lapaʻau hou, kū mau ka hui ma waena o ka honua ʻoihana kiʻekiʻe hoʻokomo kālā i ka noiʻi a me ka hoʻomohala ʻana.

Loaʻa nā huahana Novartis ma kahi o 800 miliona mau kānaka a puni ka honua a ke ʻimi nei mākou i nā ala hou e hoʻonui i ke komo ʻana i kā mākou lapaʻau hou. Ma kahi o 110,000 poʻe o nā lāhui ʻoi aku ma mua o 140 e hana ana ma Novartis a puni ka honua.

ʻO Vifor Pharma

ʻO Vifor Pharma Group kahi hui lāʻau lapaʻau honua. Manaʻo ia e lilo i alakaʻi honua i ka hao a me ka nephrology me ka nānā ʻana i nā maʻi maʻamau. ʻO ka hui ka hoa koho no nā lāʻau lapaʻau a me nā mea hoʻonā hoʻomanawanui.

Hoʻoikaika ʻo Vifor Pharma Group e kōkua i nā poʻe maʻi a puni ka honua me nā maʻi koʻikoʻi a me nā maʻi maʻi e alakaʻi i nā ola maikaʻi aʻe.

Bachem

Ua hoʻokumu ʻia ʻo Bachem ma 1971 e Peter Grogg e like me Bachem Feinchemikalien AG me ʻelua mau limahana ma Liestal kokoke i Basel me ka nānā ʻana i ka peptide synthesis. Ma 1977, neʻe ʻo Bachem i Bubendorf me ʻewalu mau limahana a ma 1978 i hana i nā peptides no ka hoʻohana ʻana i ka lāʻau lapaʻau ma lalo o nā alakaʻi GMP no ka manawa mua. Ma waena o 1981 a me 1991, ua hoʻonui ʻia ʻo Bachem i kona mana hana, ʻoiai ua piʻi ka nui o nā limahana i 150. Ma 1995, ua hoʻonui ʻia nā mea hana, me ka ʻoihana hoʻomalu maikaʻi, i ka huina o 168,000 sq. ft. (15,600 m2). Ua piʻi ka nui o nā limahana i 190.

Hoʻomaka ka hoʻonui ʻana i nā mākeke non-European me ka hoʻokumu ʻana o Bachem Bioscience, Inc. ma Philadelphia, USA, ma 1987. No ka hoʻoikaika ʻana i kona noho ʻana ma ʻEulopa, ua wehe ʻo Bachem i nā kikowaena kūʻai aku a kūʻai aku ma Germany ma 1988 a ma Palani i ka makahiki 1993. I ka makahiki 1996, ua loaʻa iā ia ka lua o ka mea hana nui o nā peptides, Bachem Kaleponi ma Torrance, USA, me kāna mau lālā ma Germany a me UK.

Hele ʻo Bachem i ka lehulehu ma Iune 18, 1998. Ua helu ʻia nā ʻāpana ma ka Swiss Stock Exchange. Ua loaʻa i ka Pūʻulu ke kūʻai aku o 96 miliona CHF a hoʻohana i 331 poʻe ma ka honua holoʻokoʻa. I ka makahiki 1999, ua loaʻa iā Bachem ka Peninsula Laboratories, Inc., i hoʻokumu ʻia ma San Carlos, Kaleponi, a me kāna ʻoihana ma ʻEnelani, i hoʻohui ʻia me Bachem UK - ʻo ia iho he lālā o California-based Bachem Inc. ma 2000.

ʻO ka loaʻa ʻana o Sochinaz SA, kahi mea hana kūikawā ma Swiss (Vionnaz) o nā mea lāʻau lapaʻau ikaika i ka makahiki 2001, ua hoʻoikaika i ka ʻike o Bachem a hoʻonui hou i kāna mau hana hana. Ua ulu ka poʻo o ka Pūʻulu i kēia manawa i nā limahana 500 a hiki ke kūʻai aku i 141,4 miliona CHF.

No laila ʻo kēia ka papa inoa o nā ʻoihana lāʻau lapaʻau kiʻekiʻe Swiss e pili ana i ke kūʻai aku i kēia makahiki i hala.

Heluhelu hou e pili ana ʻO nā ʻoihana Pharma kiʻekiʻe ma India.

Nāʻike e pili ana

E haʻalele i kahi REPLY

Eʻoluʻolu e kau i kāu manaʻo!
Eʻoluʻolu e kau i kou inoa maʻaneʻi